From human genome editing to cell and gene therapies, innovation in the biotechnology industry is reaching unprecedented levels. With the promise of new treatments and cures for patients, healthcare systems will need to adapt to ensure adequate access. This session will shed light on some of the opportunities and challenges facing countries in the wake of these new breakthroughs.

Session ID: 546634